Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2025-12-26 @ 2:09 AM
Study NCT ID:
NCT01138605
Status:
COMPLETED
Last Update Posted:
2019-05-01
First Post:
2010-04-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
TMC114-TiDP29-C232 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir (Rtv) for Children Coming From Any of the Three Ongoing Tibotec Sponsored Pediatric Studies With DRV
Sponsor:
Janssen Sciences Ireland UC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-10-13
Start Date Type:
ACTUAL
Primary Completion Date:
2017-11-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-11-23
Completion Date Type:
ACTUAL
First Submit Date:
2010-04-08
First Submit QC Date:
None
Study First Post Date:
2010-06-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-29
Last Update Post Date:
2019-05-01
Last Update Post Date Type:
ACTUAL